WebGeneric Name & Formulations: Thiotepa 15mg; per vial; lyophilized pwd for IV, intravesical, or intracavitary administration after reconstitution. WebSMC No. 790/12. Thiotepa (Tepadina®) in combination with other chemotherapy as conditioning treatment in adults or children with haematological diseases, or solid tumours prior to haematopoietic stem cell transplantation (July 2012) Not recommended.
The impact on outcomes by using thiotepa in tandem transplan ... - LWW
WebSep 21, 2024 · Generic name: thiotepa [ THYE-oh-TEP-a ] Brand names: Tepadina, Thioplex Dosage form: injectable powder for injection (100 mg; 15 mg; 30 mg) Drug class: Alkylating agents Medically reviewed by Drugs.com on Sep 21, 2024. Written by Cerner Multum. Uses Warnings Before taking Side effects Interactions Dosage What is thiotepa? Thiotepa (INN ), sold under the brand name Tepadina, is a medication used to treat cancer. Thiotepa is an organophosphorus compound with the formula (C2H4N)3PS. It is an analog of N,N′,N′′-triethylenephosphoramide (TEPA), which contains tetrahedral phosphorus and is structurally akin to phosphate. It is … See more Thiotepa is indicated for use in combination with other chemotherapy agents to treat cancer. This can be with or without total body irradiation (TBI), as a conditioning treatment prior to allogeneic or autologous See more The main side effect of thiotepa is bone marrow suppression resulting in leukopenia, thrombocytopenia and anemia. Liver and lung toxicity may … See more • "Thiotepa". Drug Information Portal. U.S. National Library of Medicine. See more Thiotepa was developed by the American Cyanamid company in the early 1950s and reported to media outlets in 1953. In 1959, thiotepa was … See more normally closed relay wiring
SECTION 1: IDENTIFICATION
WebSep 17, 2024 · A composition according to the present invention can very effectively prevent, ameliorate, or treat gastric cancer, specifically intractable gastric cancer, by screening a subject with suitable generic characteristics for a drug capable of suppressing caveolin-1-mediated endocytosis, and administering the drug into the screened subject. WebN,N'N'-triethylenethiophosphoramide (ThioTEPA) is a cancer chemotherapeutic member of the alkylating agent group, now in use for over 50 years. It is a stable derivative of N,N',N''- triethylenephosphoramide (TEPA). It is mostly used to treat breast cancer, ovarian cancer … WebSep 12, 2024 · Background. Thiotepa (thye' oh tep' a) is an ethylenimine similar in structure and activity to altretamine and is believed to act as an alkylating agent. The alkylating agents act by causing modification and … normally closed relay narva